Related Experiment Video

Updated: Jun 23, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

The kidney, hypertension, and remaining challenges

Nitin Khosla1, Rigas Kalaitzidis, George L Bakris

  • 1Department of Medicine, Section of Nephrology and Hypertension, University of California at San Diego, San Diego, CA, USA.

The Medical Clinics of North America
|May 12, 2009
PubMed

Insights

Hypertension management is crucial for preventing chronic kidney disease. Achieving blood pressure control requires better understanding of renin-angiotensin-aldosterone system blockers and more aggressive treatment for kidney patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Public Health

Background:

  • Chronic kidney disease (CKD) is a major health issue in Western countries.
  • Hypertension is the second leading cause of CKD.
  • Current blood pressure control rates in the US are below 50%.

Purpose of the Study:

  • To address challenges in hypertension treatment for CKD prevention.
  • To improve understanding and application of renin-angiotensin-aldosterone system blockers.
  • To clarify the use of fixed-dose combination therapy and aggressive blood pressure lowering in kidney patients.

Main Methods:

  • Review of current clinical practices and guidelines for hypertension management.
  • Analysis of treatment strategies for patients with CKD.
  • Identification of knowledge gaps in the medical community regarding antihypertensive therapies.

Main Results:

  • A significant gap exists in the understanding of renin-angiotensin-aldosterone system blockers.
  • Optimal initiation of fixed-dose combination therapy requires further clarification.
  • Kidney disease patients necessitate more aggressive blood pressure reduction targets.

Conclusions:

  • Enhanced education on renin-angiotensin-aldosterone system blockers is needed for clinicians.
  • Clearer guidelines for initiating combination therapy are essential.
  • Aggressive blood pressure management is vital for patients with kidney disease to prevent progression to end-stage renal disease.

More Related Videos

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...